Aruba

Dr. Renee Jones, Pharm D.

Director of Pharmacy, Personal Physician Care

Renee Jones is a licensed pharmacist in the states of Florida and New Jersey. She began her career in healthcare in 2006 as the Clinical Pharmacy Coordinator of Hunterdon Medical Center and Assistant Professor at the Ernest Mario School of Pharmacy at Rutgers University in New Jersey. She then relocated to South Florida to serve as the Pharmacy Operations Supervisor, Clinical Coordinator, and Residency Program Coordinator of Broward Health Medical Center for 8 years. During this tenure, her focus was to improve patient care, contain cost, and promote safe practices as it relates to Joint Commission standards and clinical guidelines. As the Director of Pharmacy Partnerships and Innovations at Nova Southeastern University, she worked with numerous providers, accountable care organizations (ACOs), and management services organizations (MSOs) to improve quality benchmark measures and initiate strategic plans related to annual wellness visits, chronic care management, incident to billing, post-acute discharge home visits, and transitional care medicine. She now practices as the Director of Pharmacy at Personal Physician Care. Her core responsibilities within the ACOs and MSOs is to reduce hospital admissions and ER visits, target high risk / high cost patients to improve morbidity and reduce costs, and supervise chronic care management and transitional care management teams.

Friday June 25, 2021

NEW DRUG UPDATE

ACPE # TBA

Objectives:

1.  Discuss the clinical indications for the new medications approved by the FDA.

2. Explain the various mechanisms of action for the medications discussed within this program.

3.  Recognize the clinically relevant drug interactions for the medications.

4.  Identify the most common adverse reactions for the new drug approvals.

5.  Explain the approved dosing guidelines and recommended dosage adjustments for the medications reviewed.

——————————————————————————————————————————————-

Saturday June 26, 2021

TRANSITIONS IN CARE: THE NEXTGEN PHARMACIST

ACPE # 0043-9999-20-030-L04-P

Objectives:

1.  Assess how population health and quality benchmark measures financially impact a medical organization.
2. Educate pharmacists on Current Procedural Technology (CPT) codes that can be used without provider status.
3. Describe how Accountable Care Organizations (ACOs) and Management Services Organizations (MSOs) can reduce health care costs and improve the quality of care.
4. Identify numerous areas in which pharmacists have affected patient outcomes and cost savings using population health data.
5. Discuss Medicare endorsed clinical programs that pharmacists can offer primary care provider using a financial pro format.

Sunday June 27, 2021 

PHARMACIST ROLE IN IMPROVING ANTIMICROBIAL PRESCRIBING IN OUTPATIENT SETTING

ACPE # TBA

Objectives:

1.  Understand the pathophysiology, diagnosis, and therapy of patients with various infectious diseases.
2.  Assess laboratory values, cultures, and sensitivities utilized for appropriate prescribing of antimicrobials.
3.  Discuss the mechanism of action of antimicrobials and how microbial resistance impacts therapeutic goals.
4.  Apply information learned utilizing patient cases.
5.  Determine how knowledge-based learning of infectious diseases can impact the retail pharmacists role in patient centered healthcare.